Press Release

1st May 2018

Waterloo Health Chooses SmartMed for HBA1C Self Monitoring Service

Waterloo Health and innovative MedTech company SmartMed are collaborating to run a digital health pilot scheme to improve the health and wellbeing of patients suffering with Type 2 Diabetes.

The innovative, award winning[1] SmartMed service helps reduces the number of clinic visits, making care more responsive to the women but also reducing costs for both for the hospital NHS Trust and the patient.

Dr George Verghese, General Practitioner at Waterloo Health said “SmartMed has the real potential of improving health outcomes in diabetic patients in General Practice with a supporting digital platform. We chose SmartMed as in the preliminary stages of the project they actively listened to the needs of our clinicians and the patients to create a great product”.

A number of patients already diagnosed with Type 2 diabetes are being provided with the SmartMedTM self-care package, which includes an intuitive smartphone app called HomeCare, and a Bluetooth®-connected glucometer. The device seamlessly connects to the SmartMed HomeCare app running on the patient’s own Apple or Android smart phone, which connects securely to the SmartMed Clinical Portal which allows the doctors to monitor the patient’s progress, making timely interventions only when needed.

The app intuitively guides the patient through the simple process of capturing blood sugar levels up to seven times a day (before and after various meal times).

Importantly HomeCare also asks the patient a series of simple questions, in order to elicit other possible symptoms of potential complications and to provide the clinicians with information on the patient’s overall well being.

The app also provides a communication path between the patient and their doctor, reducing stress levels by ensure easy communication between the pregnant woman and her clinician. No more phone calls waiting to be answered and only to be diverted from one person to another.

The aim is to improve the level of care provided to the patient and to enable the patient to take a more active and proactive role in the management of their diabetes, setting diets, weight loss goals, monitoring sugar levels and creating effective exercise plans.

SmartMed Business Development Director, Saadi Hussain said “This collaboration with Waterloo Health builds on previous pilots we’ve done with the NHS looking empowering patients with Gestational Diabetes, Hypertension and Respiratory conditions to self-manage their condition. Empowering patients to take control of their own chronic condition is the most cost effective way to overcome the burden that the NHS faces. Technology such as SmartMed is at the forefront of addressing this challenge head on.

The objectives of this particular pilot are to capture data about the ease of use of digital health services and to gather evidential data regarding the real benefits to the patients’ health outcomes and the potential cost savings the NHS can make through the exploitation of MedTech and Digital Health innovations.